Related Experiment Videos
Paradoxical emetic response to antiemetic treatment in cancer patients
The New England Journal of Medicine
|December 18, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.
British journal of cancer·2014
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer.
Breast cancer research and treatment·2013
Attitudes of patients with metastatic breast cancer toward research biopsies.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.
Breast cancer research and treatment·2011
Endocrine treatment options for advanced breast cancer--the role of fulvestrant.
European journal of cancer (Oxford, England : 1990)·2005
Advances in Systemic Treatment of Breast Cancer.
The New England journal of medicine·2026
Optogenetic Therapy for Restoring Aspects of Visual Function.
The New England journal of medicine·2026
Development and implementation of a standardized audit tool for cytotoxic drug preparation practices in oncology.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
PET imaging enables direct evaluation of ferroptosis in HCC synergistically induced by anti-PD-L1 and Olaparib.
Experimental & molecular medicine·2026
Guiding Risk Reduction for Breast Cancer-Relevant Chemicals (BC-Chems): Chemical Production Volumes, Sources, Intake Levels, Emissions, and Regulations.
Environmental health perspectives·2026